Primary Job Title Board Of Directors Primary Organization Forbius
Gender Male
Professional Development
Currently Independent Management Consultant in the Life Sciences Industry, Brookline, MA, USA
2012 - 2014 Vice President, Development, CoStimm Pharmaceuticals Inc., Brookline, MA, USA
2011 - 2012 Independent Scientific Consultant
2009 - 2011 Director, Pre-clinical Development, Alfama, MA, USA
2007 - 2009 Consultant
to HealthCare Ventures (HCV) and Edmond de Rothschild Investment Partners (EdRIP)
1996 - 2007 Executive Vice President, Science and Technology, ImmunoGen, Inc. Cambridge, MA, USA
1994 - 1996 Senior Vice President, Research and Development, ImmunoGen, Inc. Cambridge, MA, USA
1995 - 2006 Member of the Supervisory Board of ImmunoGen, Inc. Cambridge, MA, USA
1987 - 1994 Vice President Research, ImmunoGen, Inc. Cambridge, MA, USA
1987 - 1996 Lecturer in Pathology, Division of Tumor Immunology, Dana-Farber Cancer Institute, Harvard Medical School, USA
1986 - 1987 Assistant Professor in Pathology, Division of Tumor Immunology, Dana-Farber Cancer Institute, Harvard Medical School, USA
1981 - 1986 Assistant Professor in Pathology, Division of Tumor Immunology, Dana-Farber Cancer Institute, Harvard Medical School, USA
Education
1978 - 1981 Postdoctoral Fellow, Chemistry Department, Harvard University, Cambridge, MA, USA
1978 Dr.sc.nat. (Chemistry) Swiss Federal Institute of Technology, Zurich (ETH Zürich); Awarded the ETH Zürich Silver Medal for outstanding thesis
1973 M.S. (Chemistry) Swiss Federal Institute of Technology, Zurich (ETH Zürich)
Membership in other Supervisory Boards and other current mandates
Currently no other mandates.
Dr. Blättler is a member of MorphoSys AG's Supervisory Board since 2007.
